• Users Online: 73
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2015  |  Volume : 52  |  Issue : 1  |  Page : 30-35

Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients

1 Department of Research Centre, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey
2 Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey
3 Department of Nutrition and Diet, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey
4 Department of Medical Biochemistry, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey
5 Department of Histology and Embryology, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey
6 Department of Medical Biology, Cumhuriyet University, Faculty of Medicine, Sivas, Turkey, Turkey

Correspondence Address:
Dr Meral Yilmaz
Department of Research Centre, Faculty of Medicine, Cumhuriyet University, Sivas
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 25815864

Rights and PermissionsRights and Permissions

Objective: In this case-control study, we investigated whether IL-6 (-174G/C) and TNF-α (-308G/A) gene polymorphisms affect the clinical course and outcome of CCHF. Methods: Total 150 patients with CCHF and 170 controls were examined in this study. Genotyping of these polymorphisms were performed by PCR-RFLP methods. Results: We found no statistically significant differences in genotype and allele frequencies of these polymorphisms between patients and controls [(χ2 = 1.31, p = 0.51 for TNF-α) and (χ2 = 2.61, p = 0.27 for IL-6)]. Either TNF-α AA or IL-6 CC genotypes in dead cases were not observed in this study. Frequency of heterozygous genotypes in both IL-6 (GC) and TNF-α (GA) was higher in dead patients than living patients. However, the difference was not statistically significant. A significant difference was found in AST levels and INR when compared to patients with CCHF who died and who survived [OR = 13.9 (95% CI = 1.79-107) for INR, p = 0.01] and [OR = 23.3 (95% CI = 3.62-149) for AST, p = 0.001], respectively. Conclusion: We did not find a significant association of IL-6 -174G/C and TNF-α -308G/A polymorphisms on the prognosis of CCHF and mortality in this study. We suggest that AST and INR may be important biomarkers for determining the risk of severity and death as a result of infection with Crimean-Congo hemorrhagic fever virus (CCHFV).

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal